Only 15,400 Massachusetts General Brigham patients underwent cancer screenings during the first peak of the COVID-19 pandemic between March and June 2020, compared with 64,269 patients during the previous quarter, which may have resulted in nearly 1,400 missed cancers and precancerous lesions, according to a research letter in JAMA Oncology. However, researchers found that the number of cancer screenings rose to about 52,000 during the quarter after the pandemic's initial peak.
Pandemic-related cancer screening drop's impact examined
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.